A summary of bortezomib use in transplantation across 29 centers.
about
Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trialProteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patientsMinimal effect of bortezomib in reducing anti-pig antibodies in human leukocyte antigen-sensitized patients: a pilot study.The effect of combination therapy with rituximab and intravenous immunoglobulin on the progression of chronic antibody mediated rejection in renal transplant recipients.Proteasome inhibitors: an expanding army attacking a unique target.Postoperative care of the transplanted patient
P2860
A summary of bortezomib use in transplantation across 29 centers.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A summary of bortezomib use in transplantation across 29 centers.
@ast
A summary of bortezomib use in transplantation across 29 centers.
@en
type
label
A summary of bortezomib use in transplantation across 29 centers.
@ast
A summary of bortezomib use in transplantation across 29 centers.
@en
prefLabel
A summary of bortezomib use in transplantation across 29 centers.
@ast
A summary of bortezomib use in transplantation across 29 centers.
@en
P1433
P1476
A summary of bortezomib use in transplantation across 29 centers.
@en
P2093
Matthew J Everly
P304
P577
2009-01-01T00:00:00Z